Applied Therapeutics Inc. (APLT) closed at $22.86 in the latest trading session, marking a -0.95% move from the prior day. This move lagged the S&P 500’s daily gain of 0.88%. Elsewhere, the Dow gained 0.57%, while the tech-heavy Nasdaq added 1.39%.
Prior to today’s trading, shares of the company had lost 5.87% over the past month. This has lagged the Medical sector’s gain of 3.5% and the S&P 500’s gain of 3.54% in that time.
Wall Street will be looking for positivity from APLT as it approaches its next earnings report date. In that report, analysts expect APLT to post earnings of -$0.84 per share. This would mark a year-over-year decline of 33.33%.
Investors should also note any recent changes to analyst estimates for APLT. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company’s business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. APLT is currently a Zacks Rank #4 (Sell).
The Medical – Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 185, which puts it in the bottom 27% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks